All News

I Holland to host a solutions-led seminar focusing on resolving tablet compression issues.

This legal form of company strengthens its position as a full-service CDMO and ensures its place as an industry leader.

CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.

Leading Swiss Distributor, OMYA, partners with LODAAT for distribution of LODAAT Premium botanical molecules in USA market.  OMYA will distribute select products and add LODAAT's premium pharma-grade ingredients to its current product line.
F...

Initial base award secures additional Imvamune bulk contract of USD 100 million.

New production line for the aseptic filling of biotech medicines under isolator.

Jordan Sweden Medical and Sterilization Company (JOSWE® Medical) is still committed to its mission: to improve people’s health by developing and providing high quality branded first generic medicines at affordable prices.
We delivered...

The 30-million-euro investment will accommodate the growing needs of customers.

Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.

Partnership will provide SGS clients with a unique additional analytical service that uses cutting-edge technology to verify product authenticity, process authenticity and product/process infringement.

CDMO partners with Pall Life Sciences to deliver an end-to-end single-use platform solution from upstream to downstream.

New center of excellence to support further development of collaborative, long-term partnerships with leading pharmaceutical companies.

CPHI onsite survey highlights emerging trends in 2017 for South Korean pharma.

The importance of ensuring a facility has the right capabilities when selecting a CMO to handle high potency ingredients.

Largest ever CPHI Pharma Awards receives 200+ entries, with judges evaluating over 250,000 words.

Berry Global announces the launch of RisdropTM, an innovative, user independent eye dropper with a unique nozzle technology.
RisdropTM design has excellent flow control with low drop size variance, delivering one reliable and consistent d...

CDMO on target to become a one-source contract partner for early-phase development.

Project will use the company's Alphamer technology, which is based on 'programmable immunity' in which chemically synthesized molecules redirect naturally occurring antibodies to selected pathogens to fight the infection.

Two free webinars - 'Lyophilizer Sublimation and Heat Transfer Modelling' and 'The Freezing Stage in Freeze Drying: Fundamental Concepts 2.0' - delivered by industry experts.

Won the first position in Food and Agro products category in India for highest export for 2014-2015 under export excellence awards.

Lodaat was awarded Best Exporter from the Illinois Governor's Office for 2nd year.  This prestigious honor was awarded because of Lodaat's export volume, and reputation

CARLO ERBA Reagents is pleased to offer a new versatile solvent : 4-Methyltetrahydropyran (MTHP).
This new hydrophobic cyclic ether is an excellent substitute to THF or 2-Methyl THF in various applications (Grignard reactions, LAH reduction, cross...

Award-winning building protected by special construction against vibration and temperature fluctuations.

The European Commission has recently announced the approval of the PREMIUM proposal: “Preservation of microorganisms by understanding the protective mechanisms of oligosaccharides”, submitted to the call: H2020-MSCA-RISE-2017.

The Marie Sklo...

Nitika had  started  Additional site of  production. Since our Old site of production is Under Renovation. We Started our commercial production for the products mentioned in FDA license R...

Whether you're a small, virtual firm or Big Pharma, Recipharm Pathway to Clinic can remove the complexity out of first in human projects.

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestone...

The combination therapy reduced the risk of death by 37% versus standard of care, sunitinib, in intermediate- and poor-risk patients.

Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products.

The drug is the first and only fully human monoclonal antibody of its kind, uniquely designed to specifically block the CGRP receptor, which plays a critical role in activation of migraine.

CPHI FRANKFURT

The time it takes to develop a solution has been gravely underestimated by a large part of the industry.

Important step in executing science and technology focused strategy.

In connection with the $60 million settlement, the company has also resolved several private whistle-blower cases related to the government's investigation.

Majority of the positions eliminated expected to come from a US voluntary early retirement program.

Major new tiotropium bromide DPI development programme accelerated through licensing of Pulmatrix technology.

"The Diabetic Corner” wins the best project in the category “Innovation in the pharmacy with the patient at centre stage” at  FarmacistaPiù event, staged in Milan on 8-10 May 2015.

Cosmofarma, the leading pharmacy world event in Europe, rewards the Harmonium Pharma project as part of the Innovation & Research Award, in the category “Pharmacy management”.

The headquarters of Harmonium Innovation, the research and development company of the Harmonium Group, will be incorporated in the prestigious “Technology Park in Gran Canaria”.

A complete path to accompany people with diabetes from early screening to prevention and care of Diabetic Foot

Good news for diabetic people comes from a study conducted by Dr. Andrea Scaramuzza of the Luigi Sacco Hospital (Milan), the results of which were presented at the 51st EASD (European Association for the Study of Diabetes) Congress in Stockholm.

The pivotal Phase III study demonstrated that treatment with Abraxane in combination with gemcitabine can offer patients a median overall survival improvement of 1.8 months.

Rigontec’s immuno-oncology approach of engaging the innate immune system to safely eliminate cancer cells complements Merck's strategy and current pipeline.

PARADIGMS is a first of its kind study in pediatric MS. Other current treatments have not been evaluated in head to head trials specifically designed for children and adolescents.

After another successful year which saw the Wasdell Group add Contract Manufacturing to its already well established outsourcing services, the UK based Wasdell Group will be launching their QP Services capabilities at CPHI in Frankfurt in October.
...